Karyopharm Therapeutics Inc KPTI:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:51 PM EDT
6.01quote price arrow down-0.06 (-0.99%)
Volume
347,942
Close
6.07quote price arrow up+0.27 (+4.66%)
Volume
3,026,939
52 week range
4.42 - 18.00
Loading...
  • Open5.82
  • Day High6.10
  • Day Low5.66
  • Prev Close5.80
  • 52 Week High18.00
  • 52 Week High Date01/05/21
  • 52 Week Low4.42
  • 52 Week Low Date08/20/21

Key Stats

  • Market Cap458.29M
  • Shares Out75.50M
  • 10 Day Average Volume1.28M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change-60.79

KEY STATS

  • Open5.82
  • Day High6.10
  • Day Low5.66
  • Prev Close5.80
  • 52 Week High18.00
  • 52 Week High Date01/05/21
  • 52 Week Low4.42
  • 52 Week Low Date08/20/21
  • Market Cap458.29M
  • Shares Out75.50M
  • 10 Day Average Volume1.28M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change-60.79

RATIOS/PROFITABILITY

  • EPS (TTM)-2.80
  • P/E (TTM)-2.17
  • Fwd P/E (NTM)-2.26
  • EBITDA (MRQ)-184.64M
  • ROE (MRQ)-891.04%
  • Revenue (MRQ)102.29M
  • Gross Margin (MRQ)96.52%
  • Net Margin (MRQ)-203.25%
  • Debt To Equity (MRQ)-362.53%

EVENTS

  • Earnings Date11/01/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Karyopharm Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company. It is focused on the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (CRM1). Its lead compound, XPOVIO (selinexor), is marketed in combination with Velcade (bortezomib) and dexamethasone...
Richard Paulson
President
Michael Mason CPA
Chief Financial Officer
Ran Frenkel
Executive Vice President
Tanya Lewis
Executive Vice President
Jatin Shah M.D.
Executive Vice President
Address
85 Wells Ave
Newton Center, MA
02459-3298
United States

Top Peers

SYMBOLLASTCHG%CHG
HBIO
Harvard Bioscience Inc
7.66-0.21-2.67%
VSTM
Verastem Inc
2.76+0.06+2.22%
JNCE
Jounce Therapeutics Inc
7.79-0.06-0.76%
ATNX
Athenex Inc
3.50-0.06-1.69%
EOLS
Evolus Inc
8.22+0.13+1.61%